marketcaparena
Search

    UNH

    UNITEDHEALTH GROUP INC

    Company overview

    Market capitalization
    $339.14B
    Employees
    390,000
    Latest publication
    2026-09-29
    About UNITEDHEALTH GROUP INC

    UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ2 20202020-06-30 · USDQ1 20172017-03-31 · USDQ3 20162016-09-30 · USDQ2 20162016-06-30 · USDQ1 20162016-03-31 · USDQ2 20152015-06-30 · USD
    Total Revenue112,032,000,000USD111,721,000,000USD62,138,000,000USD48,723,000,000USD46,293,000,000USD46,485,000,000USD44,527,000,000USD36,263,000,000USD
    Cost Of Revenue13,375,000,000USD12,823,000,000USD42,179,000,000USD37,755,000,000USD35,165,000,000USD35,978,000,000USD34,307,000,000USD27,251,000,000USD
    Selling General Administrative14,268,000,000USD15,390,000,000USD10,001,000,000USD7,022,000,000USD7,033,000,000USD6,793,000,000USD6,758,000,000USD5,852,000,000USD
    Total Operating Expenses90,666,000,000USD89,908,000,000USD10,718,000,000USD7,555,000,000USD7,548,000,000USD7,304,000,000USD7,260,000,000USD6,117,000,000USD
    Operating Income7,991,000,000USD8,990,000,000USD9,241,000,000USD3,413,000,000USD3,580,000,000USD3,203,000,000USD2,960,000,000USD2,895,000,000USD
    Total Other Income Expense Net-1,023,000,000USD-1,027,000,000USD-430,000,000USD-283,000,000USD-269,000,000USD-271,000,000USD-259,000,000USD-151,000,000USD
    Interest Expense962,000,000USD955,000,000USD430,000,000USD283,000,000USD269,000,000USD271,000,000USD259,000,000USD151,000,000USD
    Depreciation And Amortization1,040,000,000USD—717,000,000USD533,000,000USD515,000,000USD511,000,000USD502,000,000USD379,000,000USD
    Income Before Tax6,968,000,000USD7,963,000,000USD8,811,000,000USD3,130,000,000USD3,311,000,000USD2,932,000,000USD2,701,000,000USD2,744,000,000USD
    Income Tax Expense1,298,000,000USD1,482,000,000USD2,115,000,000USD939,000,000USD1,333,000,000USD1,172,000,000USD1,074,000,000USD1,159,000,000USD
    Net Income5,670,000,000USD6,481,000,000USD6,637,000,000USD2,172,000,000USD1,968,000,000USD1,754,000,000USD1,611,000,000USD1,585,000,000USD
    Minority Interest186,000,000USD201,000,000USD59,000,000USD19,000,000USD10,000,000USD6,000,000USD16,000,000USD0USD
    Net Income Applicable To Common Shares5,484,000,000USD6,280,000,000USD6,637,000,000USD2,172,000,000USD1,968,000,000USD1,754,000,000USD1,611,000,000USD1,585,000,000USD
    Gross Profit—98,898,000,000USD19,959,000,000USD10,968,000,000USD11,128,000,000USD10,507,000,000USD10,220,000,000USD9,012,000,000USD
    Unclassified Operating Expenses——717,000,000USD533,000,000USD515,000,000USD511,000,000USD502,000,000USD265,000,000USD
    Interest Income——430,000,000USD—————
    Net Interest Income——-430,000,000USD—————
    Tax Provision——2,115,000,000USD—————
    Net Income From Continuing Ops——6,696,000,000USD2,191,000,000USD1,978,000,000USD1,760,000,000USD1,627,000,000USD1,585,000,000USD
    Ebit——9,241,000,000USD3,413,000,000USD3,580,000,000USD3,203,000,000USD2,960,000,000USD2,895,000,000USD
    Ebitda——9,958,000,000USD3,946,000,000USD4,095,000,000USD3,714,000,000USD3,462,000,000USD3,274,000,000USD
    Reconciled Depreciation——717,000,000USD533,000,000USD515,000,000USD511,000,000USD502,000,000USD379,000,000USD
    Research Development———0USD0USD0USD0USD0USD
    Discontinued Operations———0USD0USD0USD0USD0USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Revenue223,753,000,000USD
    Cost Of Revenue26,198,000,000USD
    Selling General Administrative29,658,000,000USD
    Total Operating Expenses180,574,000,000USD
    Operating Income16,981,000,000USD
    Total Other Income Expense Net-2,050,000,000USD
    Interest Expense1,917,000,000USD
    Depreciation And Amortization2,069,000,000USD
    Income Before Tax14,931,000,000USD
    Income Tax Expense2,780,000,000USD
    Net Income12,151,000,000USD
    Minority Interest387,000,000USD
    Net Income Applicable To Common Shares11,764,000,000USD
    SourceDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USDFY 20112011-12-31 · USDFY 20102010-12-31 · USD
    Total Revenue447,567,000,000USD184,840,000,000USD157,107,000,000USD130,474,000,000USD122,489,000,000USD110,618,000,000USD101,862,000,000USD94,155,000,000USD
    Cost Of Revenue50,655,000,000USD141,454,000,000USD120,081,000,000USD97,041,000,000USD92,129,000,000USD82,749,000,000USD92,274,000,000USD85,227,000,000USD
    Gross Profit396,912,000,000USD43,386,000,000USD37,026,000,000USD33,433,000,000USD30,360,000,000USD27,869,000,000USD9,588,000,000USD8,928,000,000USD
    Selling General Administrative59,592,000,000USD28,401,000,000USD24,312,000,000USD21,681,000,000USD19,362,000,000USD17,306,000,000USD15,557,000,000USD14,270,000,000USD
    Total Operating Expenses377,948,000,000USD30,456,000,000USD26,005,000,000USD23,159,000,000USD20,737,000,000USD18,615,000,000USD1,124,000,000USD1,064,000,000USD
    Operating Income18,964,000,000USD12,930,000,000USD11,021,000,000USD10,274,000,000USD9,623,000,000USD9,254,000,000USD8,464,000,000USD7,864,000,000USD
    Total Other Income Expense Net-4,267,000,000USD-1,067,000,000USD-790,000,000USD-618,000,000USD-708,000,000USD-632,000,000USD-505,000,000USD-481,000,000USD
    Interest Expense4,002,000,000USD1,067,000,000USD790,000,000USD618,000,000USD708,000,000USD632,000,000USD505,000,000USD481,000,000USD
    Income Before Tax14,697,000,000USD11,863,000,000USD10,231,000,000USD9,656,000,000USD8,915,000,000USD8,622,000,000USD7,959,000,000USD7,383,000,000USD
    Income Tax Expense1,890,000,000USD4,790,000,000USD4,363,000,000USD4,037,000,000USD3,242,000,000USD3,096,000,000USD2,817,000,000USD2,749,000,000USD
    Net Income12,807,000,000USD7,017,000,000USD5,813,000,000USD5,619,000,000USD5,625,000,000USD5,526,000,000USD5,142,000,000USD4,634,000,000USD
    Minority Interest751,000,000USD56,000,000USD55,000,000USD1,388,000,000USD-48,000,000USD———
    Net Income Applicable To Common Shares12,056,000,000USD7,017,000,000USD5,813,000,000USD5,619,000,000USD5,625,000,000USD5,526,000,000USD5,142,000,000USD4,634,000,000USD
    Research Development—0USD0USD0USD0USD0USD0USD0USD
    Unclassified Operating Expenses—2,055,000,000USD1,693,000,000USD1,478,000,000USD1,375,000,000USD1,309,000,000USD-14,433,000,000USD-13,206,000,000USD
    Interest Income—1,067,000,000USD790,000,000USD—————
    Net Interest Income—-1,067,000,000USD——————
    Tax Provision—4,790,000,000USD4,363,000,000USD—————
    Net Income From Continuing Ops—7,073,000,000USD5,868,000,000USD5,619,000,000USD5,673,000,000USD5,526,000,000USD5,142,000,000USD4,634,000,000USD
    Ebit—12,930,000,000USD11,021,000,000USD10,274,000,000USD9,623,000,000USD9,254,000,000USD8,464,000,000USD7,864,000,000USD
    Ebitda—14,985,000,000USD12,714,000,000USD11,752,000,000USD10,998,000,000USD10,563,000,000USD9,588,000,000USD8,928,000,000USD
    Depreciation And Amortization—2,055,000,000USD1,693,000,000USD1,478,000,000USD1,375,000,000USD1,309,000,000USD1,124,000,000USD1,064,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets309,727,000,000USD312,644,000,000USD309,581,000,000USD315,269,000,000USD308,573,000,000USD309,790,000,000USD298,278,000,000USD299,309,000,000USD
    Cash And Equivalents28,585,000,000USD28,001,000,000USD24,365,000,000USD27,210,000,000USD32,020,000,000USD30,717,000,000USD25,312,000,000USD32,400,000,000USD
    Cash And Short Term Investments31,468,000,000USD31,229,000,000USD28,121,000,000USD30,614,000,000USD32,020,000,000USD34,291,000,000USD29,113,000,000USD37,134,000,000USD
    Short Term Investments2,883,000,000USD3,228,000,000USD3,756,000,000USD3,404,000,000USD3,424,000,000USD3,574,000,000USD3,801,000,000USD4,734,000,000USD
    Long Term Investments57,716,000,000USD56,788,000,000USD54,251,000,000USD52,996,000,000USD52,466,000,000USD51,863,000,000USD52,354,000,000USD48,689,000,000USD
    Total Current Assets86,860,000,000USD91,127,000,000USD90,582,000,000USD95,067,000,000USD93,699,000,000USD96,285,000,000USD85,779,000,000USD92,258,000,000USD
    Other Current Assets9,097,000,000USD8,723,000,000USD9,746,000,000USD9,019,000,000USD8,955,000,000USD35,058,000,000USD8,212,000,000USD7,639,000,000USD
    Other Non Current Assets23,995,000,000USD23,457,000,000USD23,013,000,000USD—————
    Total Liabilities203,778,000,000USD207,325,000,000USD207,883,000,000USD—————
    Total Current Liabilities111,820,000,000USD114,124,000,000USD114,897,000,000USD115,526,000,000USD110,781,000,000USD113,471,000,000USD103,769,000,000USD101,565,000,000USD
    Other Current Liabilities65,266,000,000USD25,938,000,000USD28,046,000,000USD—————
    Other Non Current Liabilities22,457,000,000USD18,897,000,000USD18,245,000,000USD—————
    Total Stockholder Equity98,447,000,000USD103,895,000,000USD—95,787,000,000USD94,724,000,000USD95,038,000,000USD92,658,000,000USD94,535,000,000USD
    Total Equity Including Noncontrolling Interest105,949,000,000USD105,319,000,000USD101,698,000,000USD—————
    Short Long Term Debt3,827,000,000USD——7,737,000,000USD5,698,000,000USD9,986,000,000USD4,545,000,000USD3,909,000,000USD
    Long Term Debt69,501,000,000USD71,440,000,000USD72,320,000,000USD72,399,000,000USD73,495,000,000USD71,285,000,000USD72,359,000,000USD74,101,000,000USD
    Deferred Revenue2,986,000,000USD3,419,000,000USD3,413,000,000USD—————
    Net Receivables46,295,000,000USD26,587,000,000USD23,018,000,000USD55,434,000,000USD52,724,000,000USD26,936,000,000USD48,454,000,000USD47,485,000,000USD
    Property Plant Equipment Net10,762,000,000USD10,667,000,000USD10,762,000,000USD11,104,000,000USD10,923,000,000USD10,734,000,000USD10,553,000,000USD10,139,000,000USD
    Goodwill110,645,000,000USD110,512,000,000USD110,499,000,000USD—————
    Intangible Assets19,749,000,000USD20,093,000,000USD20,474,000,000USD22,785,000,000USD22,510,000,000USD22,947,000,000USD23,268,000,000USD23,594,000,000USD
    Accounts Payable39,741,000,000USD38,631,000,000USD38,032,000,000USD76,214,000,000USD72,757,000,000USD70,702,000,000USD68,561,000,000USD67,031,000,000USD
    Short Term Debt3,827,000,000USD6,477,000,000USD6,069,000,000USD7,737,000,000USD5,698,000,000USD9,986,000,000USD4,545,000,000USD3,909,000,000USD
    Common Stock9,000,000USD9,000,000USD9,000,000USD9,000,000USD9,000,000USD9,000,000USD9,000,000USD9,000,000USD
    Retained Earnings100,957,000,000USD99,878,000,000USD95,603,000,000USD97,595,000,000USD97,250,000,000USD97,934,000,000USD96,036,000,000USD96,518,000,000USD
    Accumulated Other Comprehensive Income-2,519,000,000USD-2,562,000,000USD-2,061,000,000USD-2,211,000,000USD-2,535,000,000USD-2,905,000,000USD-3,387,000,000USD-2,453,000,000USD
    Inventory——3,300,000,000USD————-55,124,000,000USD
    Total Liab———209,456,000,000USD203,789,000,000USD204,621,000,000USD195,687,000,000USD194,854,000,000USD
    Other Current Liab———28,209,000,000USD29,294,000,000USD103,485,000,000USD27,346,000,000USD27,305,000,000USD
    Capital Stock———9,000,000USD9,000,000USD9,000,000USD9,000,000USD9,000,000USD
    Good Will———110,340,000,000USD107,677,000,000USD107,566,000,000USD106,734,000,000USD105,978,000,000USD
    Cash———27,210,000,000USD28,596,000,000USD34,291,000,000USD25,312,000,000USD32,400,000,000USD
    Current Deferred Revenue———3,366,000,000USD3,032,000,000USD3,296,000,000USD3,317,000,000USD3,320,000,000USD
    Net Debt———52,926,000,000USD50,597,000,000USD46,980,000,000USD51,592,000,000USD45,610,000,000USD
    Short Long Term Debt Total———80,136,000,000USD79,193,000,000USD9,986,000,000USD76,904,000,000USD78,010,000,000USD
    Common Stock Shares Outstanding———912,000,000shares910,000,000shares918,000,000shares927,000,000shares930,000,000shares
    Non Current Assets Total———220,202,000,000USD214,874,000,000USD213,505,000,000USD212,499,000,000USD207,051,000,000USD
    Non Current Liabilities Total———93,930,000,000USD93,008,000,000USD91,150,000,000USD91,918,000,000USD93,289,000,000USD
    Non Current Liabilities Other———18,369,000,000USD15,709,000,000USD15,963,000,000USD15,939,000,000USD15,174,000,000USD
    Non Currrent Assets Other———22,977,000,000USD21,298,000,000USD161,642,000,000USD19,590,000,000USD14,637,000,000USD
    Net Working Capital———-20,459,000,000USD-17,082,000,000USD-17,186,000,000USD-17,990,000,000USD-9,307,000,000USD
    Unclassified Current Liabilities———-7,737,000,000USD-5,698,000,000USD-83,984,000,000USD-4,545,000,000USD-3,909,000,000USD
    Unclassified Non Current Liabilities———3,162,000,000USD3,804,000,000USD3,902,000,000USD3,620,000,000USD4,014,000,000USD
    Unclassified Current Assets—————-3,574,000,000USD——
    Unclassified Non Current Assets—————-141,247,000,000USD—-55,844,000,000USD
    Property Plant Equipment Gross——————17,524,000,000USD—
    Other Assets———————59,858,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets309,581,000,000USD298,278,000,000USD273,720,000,000USD245,705,000,000USD212,206,000,000USD197,289,000,000USD173,889,000,000USD152,221,000,000USD
    Cash And Equivalents24,365,000,000USD25,312,000,000USD25,427,000,000USD27,911,000,000USD21,375,000,000USD16,921,000,000USD10,985,000,000USD10,866,000,000USD
    Cash And Short Term Investments28,121,000,000USD29,113,000,000USD29,628,000,000USD27,911,000,000USD23,907,000,000USD19,781,000,000USD14,245,000,000USD14,324,000,000USD
    Short Term Investments3,756,000,000USD3,801,000,000USD4,201,000,000USD4,546,000,000USD2,532,000,000USD2,860,000,000USD3,260,000,000USD3,458,000,000USD
    Long Term Investments54,251,000,000USD52,354,000,000USD47,609,000,000USD43,728,000,000USD43,114,000,000USD41,242,000,000USD37,209,000,000USD32,510,000,000USD
    Total Current Assets90,582,000,000USD85,779,000,000USD78,437,000,000USD69,069,000,000USD61,758,000,000USD53,718,000,000USD42,634,000,000USD38,692,000,000USD
    Other Current Assets9,746,000,000USD8,212,000,000USD9,839,000,000USD10,708,000,000USD9,769,000,000USD21,067,000,000USD16,567,000,000USD12,980,000,000USD
    Other Non Current Assets23,013,000,000USD———————
    Total Liabilities207,883,000,000USD———————
    Total Current Liabilities114,897,000,000USD103,769,000,000USD99,054,000,000USD89,237,000,000USD78,292,000,000USD72,420,000,000USD61,782,000,000USD53,209,000,000USD
    Other Current Liabilities28,046,000,000USD———————
    Other Non Current Liabilities18,245,000,000USD———————
    Total Equity Including Noncontrolling Interest101,698,000,000USD———————
    Long Term Debt72,320,000,000USD72,359,000,000USD58,263,000,000USD54,513,000,000USD42,383,000,000USD38,648,000,000USD36,808,000,000USD34,581,000,000USD
    Deferred Revenue3,413,000,000USD———————
    Net Receivables23,018,000,000USD48,454,000,000USD38,970,000,000USD30,450,000,000USD28,082,000,000USD12,870,000,000USD11,822,000,000USD11,388,000,000USD
    Inventory3,300,000,000USD—-68,598,000,000USD—————
    Property Plant Equipment Net10,762,000,000USD10,553,000,000USD11,450,000,000USD10,128,000,000USD8,969,000,000USD8,626,000,000USD8,704,000,000USD8,458,000,000USD
    Goodwill110,499,000,000USD———————
    Intangible Assets20,474,000,000USD23,268,000,000USD15,194,000,000USD14,401,000,000USD10,044,000,000USD10,856,000,000USD10,349,000,000USD9,325,000,000USD
    Accounts Payable38,032,000,000USD68,561,000,000USD31,958,000,000USD56,771,000,000USD49,126,000,000USD44,367,000,000USD40,695,000,000USD36,596,000,000USD
    Short Term Debt6,069,000,000USD4,545,000,000USD5,312,000,000USD3,110,000,000USD3,620,000,000USD4,819,000,000USD3,870,000,000USD1,973,000,000USD
    Common Stock9,000,000USD9,000,000USD9,000,000USD9,000,000USD10,000,000USD10,000,000USD9,000,000USD10,000,000USD
    Retained Earnings95,603,000,000USD96,036,000,000USD95,774,000,000USD86,156,000,000USD77,134,000,000USD69,295,000,000USD61,178,000,000USD55,846,000,000USD
    Accumulated Other Comprehensive Income-2,061,000,000USD-3,387,000,000USD-7,027,000,000USD-8,393,000,000USD-5,384,000,000USD-3,814,000,000USD-3,578,000,000USD-4,160,000,000USD
    Total Liab—195,687,000,000USD174,801,000,000USD159,358,000,000USD135,727,000,000USD126,750,000,000USD111,727,000,000USD95,994,000,000USD
    Total Stockholder Equity—92,658,000,000USD88,756,000,000USD77,772,000,000USD71,760,000,000USD65,491,000,000USD57,616,000,000USD51,696,000,000USD
    Other Current Liab—27,346,000,000USD58,429,000,000USD26,281,000,000USD22,975,000,000USD20,392,000,000USD14,595,000,000USD12,244,000,000USD
    Capital Stock—9,000,000USD9,000,000USD9,000,000USD10,000,000USD10,000,000USD9,000,000USD10,000,000USD
    Good Will—106,734,000,000USD103,732,000,000USD93,352,000,000USD75,795,000,000USD71,337,000,000USD65,659,000,000USD58,910,000,000USD
    Cash—25,312,000,000USD25,427,000,000USD23,365,000,000USD21,375,000,000USD16,921,000,000USD10,985,000,000USD10,866,000,000USD
    Current Deferred Revenue—3,317,000,000USD3,355,000,000USD3,075,000,000USD2,571,000,000USD2,842,000,000USD2,622,000,000USD2,396,000,000USD
    Net Debt—51,592,000,000USD42,008,000,000USD34,258,000,000USD24,628,000,000USD26,546,000,000USD29,693,000,000USD25,688,000,000USD
    Short Long Term Debt—4,545,000,000USD4,274,000,000USD3,110,000,000USD3,620,000,000USD4,819,000,000USD3,870,000,000USD1,973,000,000USD
    Short Long Term Debt Total—76,904,000,000USD67,435,000,000USD57,623,000,000USD46,003,000,000USD43,467,000,000USD40,678,000,000USD36,554,000,000USD
    Property Plant Equipment Gross—17,524,000,000USD18,489,000,000USD17,058,000,000USD14,961,000,000USD8,626,000,000USD8,704,000,000USD8,458,000,000USD
    Common Stock Shares Outstanding—929,000,000shares938,000,000shares950,000,000shares956,000,000shares961,000,000shares966,000,000shares983,000,000shares
    Non Current Assets Total—212,499,000,000USD195,283,000,000USD176,636,000,000USD150,448,000,000USD143,571,000,000USD131,255,000,000USD113,529,000,000USD
    Non Current Liabilities Total—91,918,000,000USD80,442,000,000USD70,121,000,000USD57,435,000,000USD54,330,000,000USD49,945,000,000USD42,785,000,000USD
    Non Current Liabilities Other—15,939,000,000USD14,463,000,000USD15,608,000,000USD15,052,000,000USD12,315,000,000USD10,144,000,000USD5,730,000,000USD
    Non Currrent Assets Other—19,590,000,000USD17,298,000,000USD12,258,000,000USD107,334,000,000USD102,329,000,000USD94,046,000,000USD81,019,000,000USD
    Net Working Capital—-17,990,000,000USD-20,617,000,000USD-20,168,000,000USD-16,534,000,000USD-18,702,000,000USD-19,148,000,000USD-14,517,000,000USD
    Unclassified Current Liabilities—-4,545,000,000USD-4,274,000,000USD-3,110,000,000USD-3,620,000,000USD-4,819,000,000USD-3,870,000,000USD-1,973,000,000USD
    Unclassified Non Current Liabilities—3,620,000,000USD7,716,000,000USD-14,544,000,000USD-18,317,000,000USD-15,682,000,000USD-9,982,000,000USD-8,204,000,000USD
    Other Assets——-4,695,000,000USD20,714,000,000USD107,334,000,000USD52,752,000,000USD13,810,000,000USD8,346,000,000USD
    Deferred Long Term Liab———2,769,000,000USD3,265,000,000USD3,367,000,000USD2,993,000,000USD2,474,000,000USD
    Other Liab———11,775,000,000USD15,052,000,000USD15,682,000,000USD9,982,000,000USD8,204,000,000USD
    Net Tangible Assets———-25,084,000,000USD75,045,000,000USD-14,491,000,000USD-16,666,000,000USD-14,631,000,000USD
    Unclassified Non Current Assets———-17,945,000,000USD-202,142,000,000USD-143,571,000,000USD-98,522,000,000USD-85,039,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Net Income12,151,000,000USD
    Depreciation2,069,000,000USD
    Stock Based Compensation624,000,000USD
    Deferred Income Tax411,000,000USD
    Other Non Cash Items-102,000,000USD
    Unclassified Operating Cash Flow3,020,000,000USD
    Change To Account Receivables1,481,000,000USD
    Change To Liabilities310,000,000USD
    Operating Cash Flow19,964,000,000USD
    Capital Expenditures-1,562,000,000USD
    Net Investments-2,751,000,000USD
    Other Investing Activities68,000,000USD
    Investing Cash Flow-4,245,000,000USD
    Net Debt Issuance-4,813,000,000USD
    Net Common Stock Issuance-1,287,000,000USD
    Common Dividends Paid-4,092,000,000USD
    Other Financing Activities-1,423,000,000USD
    Financing Cash Flow-11,615,000,000USD
    Effect Of Forex Changes On Cash-3,000,000USD
    Change In Cash4,220,000,000USD
    End Cash Flow28,585,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation1,029,000,000USD1,117,000,000USD1,099,000,000USD1,084,000,000USD1,061,000,000USD1,041,000,000USD1,041,000,000USD1,020,000,000USD
    Stock Based Compensation348,000,000USD176,000,000USD223,000,000USD197,000,000USD375,000,000USD187,000,000USD237,000,000USD222,000,000USD
    Deferred Income Tax540,000,000USD———————
    Other Non Cash Items304,000,000USD423,000,000USD-39,000,000USD-231,000,000USD112,000,000USD-2,531,000,000USD-846,000,000USD1,710,000,000USD
    Change To Account Receivables-3,544,000,000USD-65,000,000USD65,000,000USD4,462,000,000USD-4,462,000,000USD-2,122,000,000USD3,156,000,000USD3,691,000,000USD
    Change To Liabilities1,055,000,000USD———————
    Change In Working Capital450,000,000USD-856,000,000USD3,138,000,000USD2,630,000,000USD-2,630,000,000USD-1,809,000,000USD7,334,000,000USD-91,000,000USD
    Operating Cash Flow8,912,000,000USD———————
    Capital Expenditures-763,000,000USD-948,000,000USD-890,000,000USD-886,000,000USD-898,000,000USD-912,000,000USD-991,000,000USD-853,000,000USD
    Net Investments-2,352,000,000USD———————
    Other Investing Activities-21,000,000USD———————
    Unclassified Investing Cash Flow689,000,000USD-73,000,000USD1,186,000,000USD1,520,000,000USD589,000,000USD-1,942,000,000USD-919,000,000USD6,679,000,000USD
    Investing Cash Flow-2,447,000,000USD———————
    Net Debt Issuance-400,000,000USD———————
    Net Common Stock Issuance0USD———————
    Common Dividends Paid-2,005,000,000USD———————
    Other Financing Activities-1,418,000,000USD———————
    Unclassified Financing Cash Flow831,000,000USD-1,834,000,000USD1,114,000,000USD360,000,000USD360,000,000USD235,000,000USD867,000,000USD2,170,000,000USD
    Financing Cash Flow-2,992,000,000USD———————
    Effect Of Forex Changes On Cash-7,000,000USD———————
    Change In Cash3,636,000,000USD911,000,000USD-1,357,000,000USD-2,121,000,000USD5,405,000,000USD-7,088,000,000USD6,114,000,000USD-2,128,000,000USD
    End Cash Flow28,001,000,000USD———————
    Net Income—218,000,000USD2,543,000,000USD3,572,000,000USD6,474,000,000USD5,543,000,000USD6,055,000,000USD4,216,000,000USD
    Total Cash From Operating Activities—1,108,000,000USD5,945,000,000USD7,188,000,000USD5,456,000,000USD2,369,000,000USD13,945,000,000USD6,746,000,000USD
    Free Cash Flow—160,000,000USD5,055,000,000USD6,302,000,000USD4,558,000,000USD1,457,000,000USD12,954,000,000USD5,893,000,000USD
    Investments—-1,296,000,000USD-4,558,000,000USD-1,442,000,000USD-74,000,000USD-1,119,000,000USD-5,651,000,000USD-7,417,000,000USD
    Total Cashflows From Investing Activities—-2,611,000,000USD-4,558,000,000USD-1,442,000,000USD-74,000,000USD-1,119,000,000USD-5,651,000,000USD-7,417,000,000USD
    Net Borrowings—-1,712,000,000USD872,000,000USD-2,345,000,000USD3,911,000,000USD-460,000,000USD2,330,000,000USD—
    Total Cash From Financing Activities—-1,031,000,000USD-2,765,000,000USD-7,947,000,000USD99,000,000USD-8,342,000,000USD-2,205,000,000USD-1,196,000,000USD
    Dividends Paid—-2,002,000,000USD-2,002,000,000USD-2,000,000,000USD-1,912,000,000USD-1,932,000,000USD-1,937,000,000USD-1,935,000,000USD
    Sale Purchase Of Stock—-4,742,000,000USD4,742,000,000USD-2,545,000,000USD-3,000,000,000USD-4,972,000,000USD-956,000,000USD-486,000,000USD
    Issuance Of Capital Stock—24,000,000USD222,000,000USD221,000,000USD360,000,000USD235,000,000USD867,000,000USD258,000,000USD
    Begin Period Cash Flow—27,210,000,000USD28,596,000,000USD30,717,000,000USD25,312,000,000USD32,400,000,000USD26,286,000,000USD28,414,000,000USD
    End Period Cash Flow—28,121,000,000USD27,210,000,000USD28,596,000,000USD30,717,000,000USD25,312,000,000USD32,400,000,000USD26,286,000,000USD
    Other Cashflows From Investing Activities—-294,000,000USD-296,000,000USD-634,000,000USD309,000,000USD2,854,000,000USD1,910,000,000USD-5,826,000,000USD
    Other Cashflows From Financing Activities—9,259,000,000USD-7,491,000,000USD-1,417,000,000USD740,000,000USD-1,213,000,000USD-2,509,000,000USD-945,000,000USD
    Unclassified Operating Cash Flow—30,000,000USD-1,019,000,000USD—64,000,000USD-62,000,000USD—-331,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Depreciation4,361,000,000USD4,099,000,000USD3,972,000,000USD3,400,000,000USD3,103,000,000USD2,891,000,000USD2,720,000,000USD2,428,000,000USD
    Stock Based Compensation971,000,000USD1,018,000,000USD1,059,000,000USD925,000,000USD800,000,000USD679,000,000USD697,000,000USD638,000,000USD
    Deferred Income Tax-1,752,000,000USD———————
    Other Non Cash Items-1,673,000,000USD4,949,000,000USD258,000,000USD673,000,000USD-944,000,000USD-52,000,000USD294,000,000USD325,000,000USD
    Change To Account Receivables-764,000,000USD-1,437,000,000USD-3,114,000,000USD-2,523,000,000USD-1,000,000,000USD-688,000,000USD162,000,000USD-1,351,000,000USD
    Change To Liabilities1,665,000,000USD——6,143,000,000USD-3,553,000,000USD5,778,000,000USD2,084,000,000USD2,395,000,000USD
    Change In Working Capital-3,542,000,000USD-808,000,000USD1,643,000,000USD2,246,000,000USD1,522,000,000USD2,895,000,000USD683,000,000USD294,000,000USD
    Operating Cash Flow19,697,000,000USD———————
    Capital Expenditures-3,622,000,000USD-3,499,000,000USD-3,386,000,000USD-2,802,000,000USD-2,454,000,000USD-2,051,000,000USD-2,071,000,000USD-2,063,000,000USD
    Net Investments361,000,000USD———————
    Other Investing Activities-4,168,000,000USD———————
    Unclassified Investing Cash Flow-1,256,000,000USD7,644,000,000USD3,661,000,000USD28,476,000,000USD-4,821,000,000USD——3,914,000,000USD
    Investing Cash Flow-8,685,000,000USD———————
    Net Debt Issuance726,000,000USD———————
    Net Common Stock Issuance-5,545,000,000USD———————
    Common Dividends Paid-7,916,000,000USD———————
    Other Financing Activities63,000,000USD———————
    Unclassified Financing Cash Flow1,028,000,000USD1,846,000,000USD1,353,000,000USD-14,298,000,000USD-4,276,000,000USD-4,296,000,000USD-4,707,000,000USD838,000,000USD
    Financing Cash Flow-11,644,000,000USD———————
    Effect Of Forex Changes On Cash40,000,000USD———————
    Change In Cash-947,000,000USD-115,000,000USD2,062,000,000USD1,990,000,000USD4,454,000,000USD5,936,000,000USD119,000,000USD-1,115,000,000USD
    End Cash Flow24,365,000,000USD———————
    Net Income—15,242,000,000USD22,381,000,000USD20,639,000,000USD17,732,000,000USD15,769,000,000USD14,239,000,000USD11,986,000,000USD
    Total Cash From Operating Activities—24,204,000,000USD29,068,000,000USD26,206,000,000USD22,343,000,000USD22,174,000,000USD18,463,000,000USD15,713,000,000USD
    Free Cash Flow—20,705,000,000USD25,682,000,000USD23,404,000,000USD19,889,000,000USD20,123,000,000USD16,392,000,000USD13,650,000,000USD
    Investments—-20,527,000,000USD-15,574,000,000USD-28,476,000,000USD-1,843,000,000USD-2,836,000,000USD-2,504,000,000USD-4,099,000,000USD
    Total Cashflows From Investing Activities—-20,527,000,000USD-15,574,000,000USD-28,476,000,000USD-10,372,000,000USD-12,532,000,000USD-12,699,000,000USD-12,385,000,000USD
    Net Borrowings—14,660,000,000USD4,280,000,000USD12,536,000,000USD2,481,000,000USD2,586,000,000USD3,994,000,000USD4,134,000,000USD
    Total Cash From Financing Activities—-3,512,000,000USD-11,529,000,000USD4,226,000,000USD-7,455,000,000USD-3,590,000,000USD-5,625,000,000USD-4,365,000,000USD
    Dividends Paid—-7,533,000,000USD-6,761,000,000USD-5,991,000,000USD-5,280,000,000USD-4,584,000,000USD-3,932,000,000USD-3,320,000,000USD
    Sale Purchase Of Stock—-9,000,000,000USD-8,000,000,000USD-7,000,000,000USD-5,000,000,000USD-4,250,000,000USD-5,500,000,000USD-4,500,000,000USD
    Issuance Of Capital Stock—1,846,000,000USD1,353,000,000USD1,253,000,000USD1,355,000,000USD1,440,000,000USD1,037,000,000USD838,000,000USD
    Begin Period Cash Flow—25,427,000,000USD23,365,000,000USD21,375,000,000USD16,921,000,000USD10,985,000,000USD10,866,000,000USD11,981,000,000USD
    End Period Cash Flow—25,312,000,000USD25,427,000,000USD23,365,000,000USD21,375,000,000USD16,921,000,000USD10,985,000,000USD10,866,000,000USD
    Other Cashflows From Investing Activities—-4,145,000,000USD-275,000,000USD-25,674,000,000USD-1,254,000,000USD-7,645,000,000USD-8,124,000,000USD-10,137,000,000USD
    Other Cashflows From Financing Activities—-3,485,000,000USD-2,401,000,000USD18,979,000,000USD4,620,000,000USD6,954,000,000USD4,520,000,000USD-1,517,000,000USD
    Unclassified Operating Cash Flow—-296,000,000USD—-1,677,000,000USD————
    Change To Inventory——1,038,000,000USD—-1,031,000,000USD-2,195,000,000USD-1,563,000,000USD-750,000,000USD
    Cash And Cash Equivalents Changes———1,956,000,000USD-40,232,000,000USD5,936,000,000USD119,000,000USD-1,115,000,000USD
    Exchange Rate Changes————-62,000,000USD-116,000,000USD-20,000,000USD-78,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Claims Incurred but Not Reported Reserve

    Period endPeriodValueUnitSource
    2026-06-30instant26,500,000,000USDDisclosure
    2026-03-31instant27,600,000,000USDDisclosure

    Favorable Prior-Years Medical Cost Reserve Development

    Period endPeriodValueUnitSource
    2026-06-30year_to_date-1,250,000,000USDDisclosure

    Medical Care Ratio

    Period endPeriodValueUnitSource
    2026-06-30quarterly86.7percentDisclosure
    2026-03-31quarter83.9percentDisclosure

    Operating Cost Ratio

    Period endPeriodValueUnitSource
    2026-06-30quarterly12.7percentDisclosure
    2026-03-31quarter13.8percentDisclosure

    Optum Health People Served

    Period endPeriodValueUnitSource
    2026-06-30instant93,000,000peopleDisclosure

    Optum Rx Adjusted Scripts Fulfilled

    Period endPeriodValueUnitSource
    2026-06-30quarterly387,000,000adjusted_scriptsDisclosure
    2026-03-31quarter383,000,000adjusted_scriptsDisclosure

    Remaining Performance Obligations

    Period endPeriodValueUnitSource
    2026-06-30instant10,700,000,000USDDisclosure
    2026-03-31instant11,000,000,000USDDisclosure

    Total UnitedHealthcare Medical People Served

    Period endPeriodValueUnitSource
    2026-06-30instant48,525,000peopleDisclosure

    UHC Commercial Fee-Based People Served

    Period endPeriodValueUnitSource
    2026-06-30instant22,265,000peopleDisclosure

    UHC Commercial Risk-Based People Served

    Period endPeriodValueUnitSource
    2026-06-30instant7,655,000peopleDisclosure

    UHC Medicaid People Served

    Period endPeriodValueUnitSource
    2026-06-30instant6,780,000peopleDisclosure

    UHC Medicare Advantage People Served

    Period endPeriodValueUnitSource
    2026-06-30instant7,565,000peopleDisclosure

    UHC Stand-Alone Medicare Part D People Served

    Period endPeriodValueUnitSource
    2026-06-30instant2,710,000peopleDisclosure

    UHC Standardized Medicare Supplement People Served

    Period endPeriodValueUnitSource
    2026-06-30instant4,260,000peopleDisclosure

    UHC Total Commercial People Served

    Period endPeriodValueUnitSource
    2026-06-30instant29,920,000peopleDisclosure

    UHC Total Community and Senior People Served

    Period endPeriodValueUnitSource
    2026-06-30instant18,605,000peopleDisclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2014Quarterly · 2014-03-31SegmentCorporateand Eliminations-8,716,000,000USD0000731766-14-000025
    Q1 2014Quarterly · 2014-03-31SegmentOptum — Intersegment Elimination-115,000,000USD0000731766-14-000025
    Q1 2014Quarterly · 2014-03-31SegmentOptum — Optumhealth2,580,000,000USD0000731766-14-000025
    Q1 2014Quarterly · 2014-03-31SegmentOptum — Optuminsight1,247,000,000USD0000731766-14-000025
    Q1 2014Quarterly · 2014-03-31SegmentOptum — Optumrx7,458,000,000USD0000731766-14-000025
    Q1 2014Quarterly · 2014-03-31SegmentUnitedhealthcare29,254,000,000USD0000731766-14-000025
    Q1 2013Quarterly · 2013-03-31SegmentCorporateand Eliminations-6,593,000,000USD0000731766-14-000025
    Q1 2013Quarterly · 2013-03-31SegmentOptum — Intersegment Elimination-108,000,000USD0000731766-14-000025
    Q1 2013Quarterly · 2013-03-31SegmentOptum — Optumhealth2,442,000,000USD0000731766-14-000025
    Q1 2013Quarterly · 2013-03-31SegmentOptum — Optuminsight1,153,000,000USD0000731766-14-000025
    Q1 2013Quarterly · 2013-03-31SegmentOptum — Optumrx5,196,000,000USD0000731766-14-000025
    Q1 2013Quarterly · 2013-03-31SegmentUnitedhealthcare28,250,000,000USD0000731766-14-000025
    Q4 2012Quarterly · 2012-12-31SegmentIntersegment Elimination-5,619,000,000USDLegacy provider
    Q4 2012Quarterly · 2012-12-31SegmentOptumhealth2,129,000,000USDLegacy provider
    Q4 2012Quarterly · 2012-12-31SegmentOptuminsight822,000,000USDLegacy provider
    Q4 2012Quarterly · 2012-12-31SegmentOptumrx4,579,000,000USDLegacy provider
    Q4 2012Quarterly · 2012-12-31SegmentUnitedhealthcare26,858,000,000USDLegacy provider
    FY 2012Yearly · 2012-12-31SegmentIntersegment Elimination-22,189,000,000USD0000731766-13-000005
    FY 2012Yearly · 2012-12-31SegmentOptumhealth8,147,000,000USD0000731766-13-000005
    FY 2012Yearly · 2012-12-31SegmentOptuminsight2,882,000,000USD0000731766-13-000005
    FY 2012Yearly · 2012-12-31SegmentOptumrx18,359,000,000USD0000731766-13-000005
    FY 2012Yearly · 2012-12-31SegmentUnitedhealthcare103,419,000,000USD0000731766-13-000005
    Q3 2012Quarterly · 2012-09-30SegmentIntersegment Elimination-5,436,000,000USD0000731766-12-000038
    Q3 2012Quarterly · 2012-09-30SegmentOptumhealth2,054,000,000USD0000731766-12-000038
    Q3 2012Quarterly · 2012-09-30SegmentOptuminsight718,000,000USD0000731766-12-000038
    Q3 2012Quarterly · 2012-09-30SegmentOptumrx4,454,000,000USD0000731766-12-000038
    Q3 2012Quarterly · 2012-09-30SegmentUnitedhealthcare25,512,000,000USD0000731766-12-000038
    Q2 2012Quarterly · 2012-06-30SegmentIntersegment Elimination-5,552,000,000USD0000731766-12-000028
    Q2 2012Quarterly · 2012-06-30SegmentOptumhealth2,025,000,000USD0000731766-12-000028
    Q2 2012Quarterly · 2012-06-30SegmentOptuminsight671,000,000USD0000731766-12-000028
    Q2 2012Quarterly · 2012-06-30SegmentOptumrx4,605,000,000USD0000731766-12-000028
    Q2 2012Quarterly · 2012-06-30SegmentUnitedhealthcare25,516,000,000USD0000731766-12-000028
    Q1 2012Quarterly · 2012-03-31SegmentIntersegment Elimination-5,582,000,000USD0000731766-13-000014
    Q1 2012Quarterly · 2012-03-31SegmentOptumhealth1,939,000,000USD0000731766-13-000014
    Q1 2012Quarterly · 2012-03-31SegmentOptuminsight671,000,000USD0000731766-13-000014
    Q1 2012Quarterly · 2012-03-31SegmentOptumrx4,721,000,000USD0000731766-13-000014
    Q1 2012Quarterly · 2012-03-31SegmentUnitedhealthcare25,533,000,000USD0000731766-13-000014
    FY 2011Yearly · 2011-12-31SegmentIntersegment Elimination-22,127,000,000USD0000731766-13-000005
    FY 2011Yearly · 2011-12-31SegmentOptumhealth6,704,000,000USD0000731766-13-000005
    FY 2011Yearly · 2011-12-31SegmentOptuminsight2,671,000,000USD0000731766-13-000005
    FY 2011Yearly · 2011-12-31SegmentOptumrx19,278,000,000USD0000731766-13-000005
    FY 2011Yearly · 2011-12-31SegmentUnitedhealthcare95,336,000,000USD0000731766-13-000005
    Q3 2011Quarterly · 2011-09-30SegmentIntersegment Elimination-5,585,000,000USD0000731766-12-000038
    Q3 2011Quarterly · 2011-09-30SegmentOptumhealth1,723,000,000USD0000731766-12-000038
    Q3 2011Quarterly · 2011-09-30SegmentOptuminsight625,000,000USD0000731766-12-000038
    Q3 2011Quarterly · 2011-09-30SegmentOptumrx4,874,000,000USD0000731766-12-000038
    Q3 2011Quarterly · 2011-09-30SegmentUnitedhealthcare23,643,000,000USD0000731766-12-000038
    Q2 2011Quarterly · 2011-06-30SegmentIntersegment Elimination-5,435,000,000USD0000731766-12-000028
    Q2 2011Quarterly · 2011-06-30SegmentOptumhealth1,670,000,000USD0000731766-12-000028
    Q2 2011Quarterly · 2011-06-30SegmentOptuminsight658,000,000USD0000731766-12-000028
    Q2 2011Quarterly · 2011-06-30SegmentOptumrx4,688,000,000USD0000731766-12-000028
    Q2 2011Quarterly · 2011-06-30SegmentUnitedhealthcare23,653,000,000USD0000731766-12-000028
    FY 2010Yearly · 2010-12-31SegmentIntersegment Elimination-18,206,000,000USD0000731766-13-000005
    FY 2010Yearly · 2010-12-31SegmentOptumhealth4,565,000,000USD0000731766-13-000005
    FY 2010Yearly · 2010-12-31SegmentOptuminsight2,342,000,000USD0000731766-13-000005
    FY 2010Yearly · 2010-12-31SegmentOptumrx16,724,000,000USD0000731766-13-000005
    FY 2010Yearly · 2010-12-31SegmentUnitedhealthcare88,730,000,000USD0000731766-13-000005
    FY 2009Yearly · 2009-12-31SegmentBusiness Intersegment Eliminations-16,028,000,000USD0000731766-12-000009
    FY 2009Yearly · 2009-12-31SegmentOptumhealth4,212,000,000USD0000731766-12-000009
    FY 2009Yearly · 2009-12-31SegmentOptuminsight1,823,000,000USD0000731766-12-000009
    FY 2009Yearly · 2009-12-31SegmentOptumrx14,401,000,000USD0000731766-12-000009
    FY 2009Yearly · 2009-12-31SegmentUnitedhealthcare82,730,000,000USD0000731766-12-000009

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.